Xinyu Chang, Bingwu Li, Wanxu Huang, Aixia Chen, Shengmin Zhu, Yueyang Liu, Xiaoling Liu, Jingyu Yang, Dan Ohtan Wang
{"title":"在急性脑缺血/再灌注过程中,YTHDF1通过m6a依赖性结合促进p53翻译并诱导铁凋亡。","authors":"Xinyu Chang, Bingwu Li, Wanxu Huang, Aixia Chen, Shengmin Zhu, Yueyang Liu, Xiaoling Liu, Jingyu Yang, Dan Ohtan Wang","doi":"10.1007/s10565-025-10061-3","DOIUrl":null,"url":null,"abstract":"<p><p>The rapid escalation of oxidative and nitrosative stress during ischemia/reperfusion (I/R) triggers neuronal damage, leading to severe neurological deficits and long-term disability. N6-methyladenosine (m<sup>6</sup>A), a highly abundant RNA modification in the brain, undergoes dynamic changes following acute I/R injury, and regulates stroke pathogenesis and neurological outcomes. However, the molecular mechanisms by which m<sup>6</sup>A influences acute I/R injury responses remain elusive. Our study reveals that the expression of key I/R pathogenesis pathways positively correlates with the expression of m<sup>6</sup>A reader proteins. Modulating expression of YTHDF1, a neuron-enriched reader protein of m<sup>6</sup>A, results in bidirectional changes in oxidative stress response and neuronal viability under I/R conditions. We have identified p53 mRNA as a critical target of m<sup>6</sup>A methylation and YTHDF1, driving the translation of p53 protein in a context- and m<sup>6</sup>A-dependent manner, which exacerbates oxidative stress and ferroptosis. This novel mechanism suggests the potential of targeting the m<sup>6</sup>A reader protein as a strategic avenue for developing neuroprotective therapies to mitigate I/R injury.</p>","PeriodicalId":9672,"journal":{"name":"Cell Biology and Toxicology","volume":"41 1","pages":"112"},"PeriodicalIF":5.3000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12213927/pdf/","citationCount":"0","resultStr":"{\"title\":\"YTHDF1 promotes p53 translation and induces ferroptosis during acute cerebral ischemia/reperfusion through m<sup>6</sup>A-dependent binding.\",\"authors\":\"Xinyu Chang, Bingwu Li, Wanxu Huang, Aixia Chen, Shengmin Zhu, Yueyang Liu, Xiaoling Liu, Jingyu Yang, Dan Ohtan Wang\",\"doi\":\"10.1007/s10565-025-10061-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The rapid escalation of oxidative and nitrosative stress during ischemia/reperfusion (I/R) triggers neuronal damage, leading to severe neurological deficits and long-term disability. N6-methyladenosine (m<sup>6</sup>A), a highly abundant RNA modification in the brain, undergoes dynamic changes following acute I/R injury, and regulates stroke pathogenesis and neurological outcomes. However, the molecular mechanisms by which m<sup>6</sup>A influences acute I/R injury responses remain elusive. Our study reveals that the expression of key I/R pathogenesis pathways positively correlates with the expression of m<sup>6</sup>A reader proteins. Modulating expression of YTHDF1, a neuron-enriched reader protein of m<sup>6</sup>A, results in bidirectional changes in oxidative stress response and neuronal viability under I/R conditions. We have identified p53 mRNA as a critical target of m<sup>6</sup>A methylation and YTHDF1, driving the translation of p53 protein in a context- and m<sup>6</sup>A-dependent manner, which exacerbates oxidative stress and ferroptosis. This novel mechanism suggests the potential of targeting the m<sup>6</sup>A reader protein as a strategic avenue for developing neuroprotective therapies to mitigate I/R injury.</p>\",\"PeriodicalId\":9672,\"journal\":{\"name\":\"Cell Biology and Toxicology\",\"volume\":\"41 1\",\"pages\":\"112\"},\"PeriodicalIF\":5.3000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12213927/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cell Biology and Toxicology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10565-025-10061-3\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CELL BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell Biology and Toxicology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10565-025-10061-3","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
YTHDF1 promotes p53 translation and induces ferroptosis during acute cerebral ischemia/reperfusion through m6A-dependent binding.
The rapid escalation of oxidative and nitrosative stress during ischemia/reperfusion (I/R) triggers neuronal damage, leading to severe neurological deficits and long-term disability. N6-methyladenosine (m6A), a highly abundant RNA modification in the brain, undergoes dynamic changes following acute I/R injury, and regulates stroke pathogenesis and neurological outcomes. However, the molecular mechanisms by which m6A influences acute I/R injury responses remain elusive. Our study reveals that the expression of key I/R pathogenesis pathways positively correlates with the expression of m6A reader proteins. Modulating expression of YTHDF1, a neuron-enriched reader protein of m6A, results in bidirectional changes in oxidative stress response and neuronal viability under I/R conditions. We have identified p53 mRNA as a critical target of m6A methylation and YTHDF1, driving the translation of p53 protein in a context- and m6A-dependent manner, which exacerbates oxidative stress and ferroptosis. This novel mechanism suggests the potential of targeting the m6A reader protein as a strategic avenue for developing neuroprotective therapies to mitigate I/R injury.
期刊介绍:
Cell Biology and Toxicology (CBT) is an international journal focused on clinical and translational research with an emphasis on molecular and cell biology, genetic and epigenetic heterogeneity, drug discovery and development, and molecular pharmacology and toxicology. CBT has a disease-specific scope prioritizing publications on gene and protein-based regulation, intracellular signaling pathway dysfunction, cell type-specific function, and systems in biomedicine in drug discovery and development. CBT publishes original articles with outstanding, innovative and significant findings, important reviews on recent research advances and issues of high current interest, opinion articles of leading edge science, and rapid communication or reports, on molecular mechanisms and therapies in diseases.